Background. Most expert networks are inherited. Some have to be built from nothing.
Methods. One physician, followed from 2017 to the present across pharmacovigilance, Medical Affairs, eight Latin American markets, a digital health start-up and a clinic that never closed.
Results. Networks, teams and a launch model were built from baseline zero and adopted beyond their market of origin.
Conclusion. Trust is the rate-limiting step. Everything else scales.
“The sample size is one. The findings may not generalise.”
We agree, and we invite replication. The full method is available in Supplementary S2.
Overlapping exposures are expected. Select a bar for details and what each period taught.
Figure 2. Exposure timeline. Purple: industry. Gold: clinical practice and independent projects. MD, Universidad Hispanoamérica · MSc Medical Scientific Liaison · ICH-GCP certified.
Hover or tap each step. Note the negative feedback loop: transactional asks inhibit the pathway.
Four situations from building engagement from zero. Choose a management plan.
A short literary one, under the pen name D. P. Reid: one passenger, seat 26D, and a flight that doesn't let go. 14,628 words. Writing it taught me what medicine did: say less, and make every word carry weight.
Free and interactive: a relationship health check, engagement from zero, a prioritisation scorer and AI prompts for your own network.
Open it →An AI-guided health platform, built as a Delaware company from an idea to a working MVP. I pitched it from San José to San Francisco (pictured: IT Summit Costa Rica).
Lesson: technology is the easy part; trust is the product.
In person and by telehealth since 2019. It's my control group for whether anything we build in industry actually reaches people.
If something here resonated, or you disagree with any of it, I'd like to hear from you.